Biogen's shakeup from the top; How to build a biotech today; David Sabatini backs out of NYU; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
Goodbyes are hard, especially when it comes to sending off a dear friend and colleague like Jason Mast, who’s leaving Endpoints. I have had the honor of being the first to read many of his stories — often in equal parts incisive and intriguing — and am truly thankful for the many ways he’s shaped the team for the better. We’ll all miss him but are also excited to see what his next chapter brings.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 144,400+ biopharma pros reading Endpoints daily — and it's free.